Page last updated: 2024-12-11

ro 13-6298

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid: used in psoriasis therapy; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6437076
CHEMBL ID22369
SCHEMBL ID2890175
SCHEMBL ID2890176
MeSH IDM0107058

Synonyms (20)

Synonym
ro-136298
ccris 5450
arotinoid ro 136298
benzoic acid, p-((e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)-, ethyl ester
brn 2014282
arotinoid ethyl ester
ethyl-p-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate
ro 13-6298
ethyl-p-((e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate
ethyl-p-((e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid
CHEMBL22369
ethyl 4-[(e)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoate
71441-09-3
SCHEMBL2890175
SCHEMBL2890176
p-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl]-benzoic acid ethyl ester
NULUAKSYPPSJCO-FBMGVBCBSA-N
p-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-propenyl]-benzoic acid ethyl ester
ethyl p-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl]benzoate
(e)-ethyl 4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Peak circulating concentrations of parent all-trans-retinoic acid were less than those observed after an equivalent oral dose, but prolonged absorption from the skin appears to contribute to high total bioavailability of topical retinoid."( Percutaneous retinoid absorption and embryotoxicity.
Allen, PV; Berry, DL; Sharma, RP; Willhite, CC, 1990
)
0.28

Dosage Studied

ExcerptRelevanceReference
" In the rodent, overt skin toxicity under continued dosing could increase the amounts of retinoid penetrating the skin and reaching the embryo."( Percutaneous retinoid absorption and embryotoxicity.
Allen, PV; Berry, DL; Sharma, RP; Willhite, CC, 1990
)
0.28
" In the present paper we test this hypothesis directly by making detailed dose-response curves."( Cultured human ectocervical epithelial cell differentiation is regulated by the combined direct actions of sex steroids, glucocorticoids, and retinoids.
Eckert, RL; Gorodeski, GI; Rorke, EA; Sheean, L; Utian, WH, 1990
)
0.28
" Intraperitoneal application of the drug at a dosage of 10 micrograms/kg/day for three consecutive days (days 9-11 or 12-14) caused severe malformations, particularly in the skeletal system and the cavernous organs."( Teratogenicity of arotinoid ethyl ester (RO 13-6298) in mice.
Stürje, H; Tsambaos, D; Zimmermann, B, 1985
)
0.54
" Because the dose-response curves for arotinoids were significantly parallel to that for all-trans-retinoic acid, and because the spectrum of congenital defects induced by arotinoids was identical to that induced by all-trans-retinoic acid and other teratogenic retinoids, the mechanism of embryopathic action of these conformationally restricted retinoids was concluded to be similar to that of all-trans-retinoic acid."( Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
Ferm, VH; Flanagan, JL; Willhite, CC, 1987
)
0.27
" We found that inhibition of chondrogenesis depended on the dosage and the duration of treatment with the different retinoids."( Evaluation of the sensitive step of inhibition of chondrogenesis by retinoids in limb mesenchymal cells in vitro.
Tsambaos, D; Zimmermann, B, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID109743Lowest daily intraperitoneal dose causing hypervitaminosis A symptoms was determined in a 2-week period in mice1982Journal of medicinal chemistry, Nov, Volume: 25, Issue:11
Retinoids at the threshold: their biological significance and therapeutic potential.
AID200398Growth inhibition of Cloudman S91 Melanoma cells at 1 uM drug concentration.1982Journal of medicinal chemistry, Aug, Volume: 25, Issue:8
Affinity therapeutics. 1. Selective incorporation of 2-thiouracil derivatives in murine melanomas. Cytostatic activity of 2-thiouracil arotinoids, 2-thiouracil retinoids, arotinoids, and retinoids.
AID420836Inhibition of Dictyostelium discoideum AX2 RNase P by double reciprocal plot2009European journal of medicinal chemistry, Jun, Volume: 44, Issue:6
Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity.
AID235613Therapeutic index calculated as the ratio of hypervitaminosis A dose to the ED50 dose1982Journal of medicinal chemistry, Nov, Volume: 25, Issue:11
Retinoids at the threshold: their biological significance and therapeutic potential.
AID114326Antipapilloma activity was determined after intraperitoneal administration in mice1982Journal of medicinal chemistry, Nov, Volume: 25, Issue:11
Retinoids at the threshold: their biological significance and therapeutic potential.
AID200399Growth inhibition of Cloudman S91 Melanoma cells at 10 uM drug concentration.1982Journal of medicinal chemistry, Aug, Volume: 25, Issue:8
Affinity therapeutics. 1. Selective incorporation of 2-thiouracil derivatives in murine melanomas. Cytostatic activity of 2-thiouracil arotinoids, 2-thiouracil retinoids, arotinoids, and retinoids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (69.39)18.7374
1990's10 (20.41)18.2507
2000's5 (10.20)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.03 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.77%)5.53%
Reviews5 (9.43%)6.00%
Case Studies6 (11.32%)4.05%
Observational0 (0.00%)0.25%
Other40 (75.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]